The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
Genomic organization of the human catechol O‐methyltransferase gene and its expression from two distinct promoters
Open accessAbstract
Human genomic DNA fragments containing catechol O-methyltransferase (COMT) sequences were isolated and the exon-intron structure analysed by sequencing, PCR and comparing to the human COMT cDNA sequences. The gene contains six exons, of which exons 1 and 2 are noncoding. MB-ATG and S-ATG codons, responsible for the initiation of translation of the membrane-bound (MB) and soluble (S) forms of the enzyme, are located in exon 3. Two distinct COMT-specific transcripts, 1.3 kb and 1.5 kb, were detected in various human tissues and cell lines. Different quantities of the shorter COMT-specific mRNA in the tissues studied suggest a tissue-specific regulation of the COMT gene at transcriptional level. Mapping of the 5' ends of the COMT mRNAs showed that transcription initiates at multiple sites in two separate DNA regions, which are preceded by functional promoter sequences. The proximal promoter (P1), located between the two translation initiation codons and extending approximately 200 bp upstream of the MB-ATG initiation codon, apparently gives rise to the 1.3-kb S-COMT mRNA (S-mRNA). The distal promoter (P2) is located in a DNA fragment in front of and partly overlapping the transcription-start region of the 1.5-kb transcript, suggesting that it controls the expression of this MB-mRNA. Similarities between the rat and human COMT gene promoters are analyzed.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The predominant form in peripheral tissue is the soluble isoform (S-COMT) [52].”
From Dynamic DNA methylation changes in the COMT gene promoter region in response to mental stress and its modulation by transcranial direct current stimulation (2021) · cites this paper as [52]
Citations
Cites
Molecular Cloning: A Laboratory Manual
Sambrook, J., Fritsch, E., & Maniatis, T. (1989) · UCLA - Biblioteca de Ciencias de la Salud · Cited by 133,589
Molecular cloning: A laboratory manual
Deininger, P. L. (1990) · Analytical Biochemistry · doi:10.1016/0003-2697(90)90595-z · Cited by 84,684
Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease
Chirgwin, J. M., Przybyla, A., MacDonald, R. J., & Rutter, W. J. (1979) · Biochemistry · doi:10.1021/bi00591a005 · Cited by 21,460
The scanning model for translation: an update.
Kozak, M. (1989) · The Journal of Cell Biology · doi:10.1083/jcb.108.2.229 · Cited by 3,485
An analysis of vertebrate mRNA sequences: intimations of translational control.
Kozak, M. (1991) · The Journal of Cell Biology · doi:10.1083/jcb.115.4.887 · Cited by 1,631
Carlson, M., & Botstein, D. (1982) · Cell · doi:10.1016/0092-8674(82)90384-1 · Cited by 1,541
A nuclear factor for IL‐6 expression (NF‐IL6) is a member of a C/EBP family.
Akira, S., Isshiki, H., Sugita, T., Tanabe, O., Kinoshita, S. M., Nishio, Y., Nakajima, T., Hirano, T., & Kishimoto, T. (1990) · The EMBO Journal · doi:10.1002/j.1460-2075.1990.tb08316.x · Cited by 1,450
Imagawa, M. (1987) · Cell · doi:10.1016/0092-8674(87)90152-8 · Cited by 1,384
Enzymatic O-methylation of epinephrine and other catechols
Axelrod, J., & Tomchick, R. (1958) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)64731-3 · Cited by 1,283
Compilation of vertebrate-encoded transcription factors
Faisst, S., & Meyer, S. (1992) · Nucleic Acids Research · doi:10.1093/nar/20.1.3 · Cited by 902
Research works printed but not linked: 1
- Guldberg H. C., 1975, Catechol‐O‐methyltransferase: Pharmacological aspects and physiological role, Pharmacol. Rev., 27, 135
Cited by
Sorted by citations
Schizophrenia genes, gene expression, and neuropathology: on the matter of their convergence
Harrison, P. J., & Weinberger, D. R. (2005) · Molecular Psychiatry · doi:10.1038/sj.mp.4001558 · Cited by 2,020
Männistö, P. T., & Kaakkola, S. (1999) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01423-6 · Cited by 1,068
Catechol-o-Methyltransferase, Cognition, and Psychosis: Val158Met and Beyond
Tunbridge, E. M., Harrison, P. J., & Weinberger, D. R. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.10.024 · Cited by 699
Complexity of dopamine metabolism
Meiser, J., Weindl, D., & Hiller, K. (2013) · Cell Communication and Signaling · doi:10.1186/1478-811x-11-34 · Cited by 726
Weinshilboum, R. M., Otterness, D. M., & Szumlanski, C. L. (1999) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.39.1.19 · Cited by 550
Hypomethylation of MB-COMT promoter is a major risk factor for schizophrenia and bipolar disorder
Abdolmaleky, H. M., Cheng, K.-H., Faraone, S. V., Wilcox, M., Glatt, S. J., Gao, F., Smith, C. L., Shafa, R., Aeali, B., Carnevale, J., et al. (2006) · Human Molecular Genetics · doi:10.1093/hmg/ddl253 · Cited by 462
Schiffer, L., Barnard, L., Baranowski, E. S., Gilligan, L. C., Taylor, A. E., Arlt, W., Shackleton, C. H. L., & Storbeck, K.-H. (2019) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2019.105439 · Cited by 450
“The highest levels of COMT are found in the liver, brain, kidney, adrenal and lungs [183].”
Genetic and neurochemical modulation of prefrontal cognitive functions in children
Diamond, A., Briand, L., Fossella, J., & Gehlbach, L. (2004) · American Journal of Psychiatry · doi:10.1176/appi.ajp.161.1.125 · Cited by 381
Global variation in the frequencies of functionally different catechol-O-methyltransferase alleles.
Palmatier, M., Kang, M. A., & Kidd, K. (1999) · Biological Psychiatry · doi:10.1016/s0006-3223(99)00098-0 · Cited by 385
Catechol- O -methyltransferase gene polymorphisms are associated with multiple pain-evoking stimuli
Diatchenko, L. B., Nackley, A. G., Slade, G. D., Bhalang, K., Belfer, I., Max, M. B., Goldman, D. A., & Maixner, W. D. (2006) · Pain · doi:10.1016/j.pain.2006.05.024 · Cited by 373
Matsumoto, M., Weickert, C. S., Akil, M., Lipska, B. K., Hyde, T. M., Herman, M. M., Kleinman, J. E., & Weinberger, D. R. (2003) · Neuroscience · doi:10.1016/s0306-4522(02)00556-0 · Cited by 365
Caraco, Y., Blotnick, S., & Muszkat, M. (2007) · Clinical Pharmacology & Therapeutics · doi:10.1038/sj.clpt.6100316 · Cited by 359
Bray, N. J., Buckland, P. R., Williams, N. M., Williams, H. J., Norton, N., Owen, M. J., & O’Donovan, M. C. (2003) · The American Journal of Human Genetics · doi:10.1086/376578 · Cited by 335
The molecular genetics of schizophrenia: new findings promise new insights
Owen, M. J., Williams, N. M., & O’Donovan, M. C. (2003) · Molecular Psychiatry · doi:10.1038/sj.mp.4001444 · Cited by 328
Genetic influences on DSMIIIR drug abuse and dependence: A study of 3,372 twin pairs
Tsuang, M. T., Lyons, M. J., Eisen, S. A., Goldberg, J. H., True, W., Lin, N., Meyer, J. M., Toomey, R., Faraone, S. V., & Eaves, L. J. (1996) · American Journal of Medical Genetics · doi:10.1002/(sici)1096-8628(19960920)67:5 · Cited by 462
Xie, T., Ho, S., & Ramsden, D. B. (1999) · Molecular Pharmacology · doi:10.1124/mol.56.1.31 · Cited by 301
Chapter 6: Estrogen Metabolism by Conjugation
Raftogianis, R. B., Creveling, C. R., Weinshilboum, R. M., & Weisz, J. (2000) · JNCI Monographs · doi:10.1093/oxfordjournals.jncimonographs.a024234 · Cited by 297
Dawling, S., Roodi, N., Mernaugh, R. L., Wang, X., & Parl, F. F. (2001) · PubMed · Cited by 250
Eisenhofer, G., Keiser, H. R., Friberg, P., Mezey, É., Huynh, T., Hiremagalur, B., Ellingson, T., Duddempudi, S., Eijsbouts, A. M. M., & Lenders, J. W. M. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.83.6.4870 · Cited by 242
Genetic Gating of Human Fear Learning and Extinction
Lonsdorf, T. B., Weike, A. I., Nikamo, P., Schalling, M., Hamm, A. O., & Öhman, A. (2009) · Psychological Science · doi:10.1111/j.1467-9280.2009.02280.x · Cited by 249
Strous, R. D., Bark, N. M., Parsia, S. S., Volavka, J., & Lachman, H. M. (1997) · Psychiatry Research · doi:10.1016/s0165-1781(96)03111-3 · Cited by 217
Craddock, N., Owen, M. J., & O'Donovan, M. C. (2006) · Molecular Psychiatry · doi:10.1038/sj.mp.4001808 · Cited by 216
Catechol‐ O ‐methyltransferase and Its Inhibitors in Parkinson's Disease
Bonifácio, M. J., Palma, P. N., Almeida, L., & Soares-da-Silva, P. (2007) · CNS Drug Reviews · doi:10.1111/j.1527-3458.2007.00020.x · Cited by 201
Personalized medicine in Parkinson's disease: Time to be precise
Titova, N., & Chaudhuri, К. R. (2017) · Movement Disorders · doi:10.1002/mds.27027 · Cited by 187
Hébert, M. F., Smith, H. E., Marbury, T. C., Swan, S. K., Smith, W. B., Townsend, R. W., Buell, D. N., Keirns, J. J., & Bekersky, I. (2005) · The Journal of Clinical Pharmacology · doi:10.1177/0091270005279580 · Cited by 181
Is COMT a Susceptibility Gene for Schizophrenia?
Williams, H. J., Owen, M. J., & O’Donovan, M. C. (2007) · Schizophrenia Bulletin · doi:10.1093/schbul/sbm019 · Cited by 181
Nohesara, S., Ghadirivasfi, M., Mostafavi, S., Eskandari, M.-R., Ahmadkhaniha, H., Thiagalingam, S., & Abdolmaleky, H. M. (2011) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2011.06.013 · Cited by 168
Human catechol-O-methyltransferase down-regulation by estradiol
Jiang, H. (2003) · Neuropharmacology · doi:10.1016/s0028-3908(03)00286-7 · Cited by 165
Massat, I., Souery, D., Del‐Favero, J., Nöthen, M. M., Blackwood, D., Muir, W. J., Kaneva, R. P., Serretti, A., Lorenzi, C., Rietschel, M., et al. (2004) · Molecular Psychiatry · doi:10.1038/sj.mp.4001615 · Cited by 162
Dopamine genes and attention-deficit hyperactivity disorder: a review
DiMaio, S., Grizenko, N., & Joober, R. (2003) · Journal of Psychiatry and Neuroscience · doi:10.1139/jpn.0303 · Cited by 153
Recent advances in the genetics of schizophrenia
O’Donovan, M. C., Williams, N. M., & Owen, M. J. (2003) · Human Molecular Genetics · doi:10.1093/hmg/ddg302 · Cited by 154
Shield, A., Thomae, B. A., Eckloff, B. W., Wieben, E. D., & Weinshilboum, R. M. (2004) · Molecular Psychiatry · doi:10.1038/sj.mp.4001386 · Cited by 152
Chen, D., Wang, C. Y., Lambert, J. D., Ai, N., Welsh, W. J., & Yang, C. S. (2005) · Biochemical Pharmacology · doi:10.1016/j.bcp.2005.01.024 · Cited by 150
Raz, N., Rodrigue, K. M., Kennedy, K. M., & Land, S. J. (2009) · Neuropsychology · doi:10.1037/a0013487 · Cited by 141
Li, T., Ball, D., Zhao, J., Murray, R. M., Liu, X., Sham, P. C., & Collier, D. A. (2000) · Molecular Psychiatry · doi:10.1038/sj.mp.4000638 · Cited by 140
Beuten, J., Payne, T. J., Ma, J. Z., & Li, M. D. (2005) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300997 · Cited by 138
COMT genetic variation confers risk for psychotic and affective disorders: a case control study
Funke, B., Malhotra, A. K., Finn, C. T., Plocik, A. M., Lake, S. L., Lencz, T., DeRosse, P., Kane, J. M., & Kucherlapati, R. (2005) · Behavioral and Brain Functions · doi:10.1186/1744-9081-1-19 · Cited by 134
Matsumoto, M., Weickert, C. S., Beltaifa, S., Kolachana, B. S., Chen, J., Hyde, T. M., Herman, M. M., Weinberger, D. R., & Kleinman, J. E. (2003) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300218 · Cited by 133
The Biochemistry of Drug Metabolism – An Introduction
Testa, B., & Krämer, S. D. (2008) · Chemistry & Biodiversity · doi:10.1002/cbdv.200890199 · Cited by 137
Cloning, expression and structure of catechol-O-methyltransferase
Lundstrom, K. H., Tenhunen, J., Tilgmann, C., Karhunen, T., Panula, P., & Ulmanen, I. (1995) · Biochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology · doi:10.1016/0167-4838(95)00071-2 · Cited by 131
Hamilton, S. P., Slager, S. L., Heiman, G. A., Deng, Z., Haghighi, F. G., Klein, D. F., Hodge, S. E., Weissman, M. M., Fyer, A. J., & Knowles, J. A. (2002) · Biological Psychiatry · doi:10.1016/s0006-3223(01)01322-1 · Cited by 129
Crystal Structures of Human 108V and 108M Catechol O-Methyltransferase
Rutherford, K., Trong, I. L., Stenkamp, R. E., & Parson, W. (2008) · Journal of Molecular Biology · doi:10.1016/j.jmb.2008.04.040 · Cited by 129
Kunugi, H., Nanko, S., Ueki, A., Otsuka, E., Hattori, M., Hoda, F., Vallada, H., Arranz, M. J., & Collier, D. A. (1997) · Neuroscience Letters · doi:10.1016/s0304-3940(96)13289-4 · Cited by 128
Variation in theCOMTGene: Implications for Pain Perception and Pain Treatment
Andersen, S. B., & Skorpen, F. (2009) · Pharmacogenomics · doi:10.2217/pgs.09.13 · Cited by 126
Functional effects of a tandem duplication polymorphism in the 5′flanking region of the DRD4 gene
D’Souza, U. M., Russ, C., Turanlı, E. T., Mill, J. S., McGuffin, P., Asherson, P. J., & Craig, I. (2004) · Biological Psychiatry · doi:10.1016/j.biopsych.2004.08.008 · Cited by 113
Lavigne, J. A., Goodman, J. E., Fonong, T., Odwin, S.-A., He, P., Roberts, D. W., & Yager, J. D. (2001) · PubMed · Cited by 113
Kunugi, H., Vallada, H., Hoda, F., Kirov, G., Gill, M., Aitchison, K. J., Ball, D., Arranz, M. J., Murray, R. M., & Collier, D. A. (1997) · Biological Psychiatry · doi:10.1016/s0006-3223(96)00366-6 · Cited by 106
Ulmanen, I., Peränen, J., Tenhunen, J., Tilgmann, C., Karhunen, T., Panula, P., Bernasconi, L., Aubry, J., & Lundstrom, K. H. (1997) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1997.0452a.x · Cited by 105
Olsson, C. A., Anney, R., Lotfi-Miri, M., Byrnes, G. B., Williamson, R., & Patton, G. C. (2005) · Psychiatric Genetics · doi:10.1097/00041444-200506000-00007 · Cited by 103
Murphy, B. C., O'Reilly, R. L., & Singh, S. M. (2005) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.30134 · Cited by 102
Heterogeneity within Animal Thioredoxin Reductases
Sun, Q.-A., Zappacosta, F., Factor, V. M., Wirth, P. J., Hatfield, D. L., & Gladyshev, V. N. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m004750200 · Cited by 101
Biological and social influences on cognitive control processes dependent on prefrontal cortex
Diamond, A. D. (2011) · Progress in brain research · doi:10.1016/b978-0-444-53884-0.00032-4 · Cited by 117
New, Selective Catechol-O-Methyltransferase Inhibitors as Therapeutic Agents in Parkinson’s Disease
Bonifati, V., & Meco, G. (1999) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(98)00032-1 · Cited by 97
Lautala, P., Ulmanen, I., & Taskinen, J. (2001) · Molecular Pharmacology · doi:10.1016/s0026-895x(24)12851-9 · Cited by 96
Qayyum, A., C. Zai, C., Hirata, Y., K. Tiwari, A., Cheema, S., Nowrouzi, B., Beitchman, J., & Kennedy, L. (2015) · Current Neuropharmacology · doi:10.2174/1570159x13666150612225836 · Cited by 95
Bai, H., Shim, J., Yu, J., & Zhu, B. T. (2007) · Chemical Research in Toxicology · doi:10.1021/tx700174w · Cited by 90
Norton, N., Kirov, G., Zammit, S., Jones, G., Jones, S., Owen, R., Krawczak, M., Williams, N. M., O’Donovan, M. C., & Owen, M. J. (2002) · American Journal of Medical Genetics · doi:10.1002/ajmg.10517 · Cited by 90
Cheuk, D., & Wong, V. (2006) · Behavior Genetics · doi:10.1007/s10519-006-9076-5 · Cited by 85
Bonifácio, M. J., Archer, M., Rodrigues, M. L., Matias, P. M., Learmonth, D. A., Carrondo, M. A., & Soares-da-Silva, P. (2002) · Molecular Pharmacology · doi:10.1124/mol.62.4.795 · Cited by 88
Bellgrove, M. A., Domschke, K., Hawi, Z., Kirley, A., Mullins, C., Robertson, I. H., & Gill, M. (2005) · Experimental Brain Research · doi:10.1007/s00221-004-2180-y · Cited by 88
The neurobiology of human aggressive behavior: Neuroimaging, genetic, and neurochemical aspects
Cupaioli, F. A., Zucca, F. A., Caporale, C., Lesch, K., Passamonti, L., & Zecca, L. (2020) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2020.110059 · Cited by 94
Handoko, H. Y., Nyholt, D. R., Hayward, N. K., Nertney, D. A., Hannah, D. E., Windus, L. C. E., McCormack, C., Smith, H. J., Filippich, C., James, M. R., et al. (2004) · Molecular Psychiatry · doi:10.1038/sj.mp.4001606 · Cited by 86
Worda, C. (2003) · Human Reproduction · doi:10.1093/humrep/deg059 · Cited by 84
Montag, C., Jurkiewicz, M., & Reuter, M. (2012) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/187152712800672382 · Cited by 83
Psychopathological aspects of dopaminergic gene polymorphisms in adolescence and young adulthood
Nemoda, Z., Szekely, A., & Sasvari-Szekely, M. (2011) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2011.04.002 · Cited by 78
DeMille, M. M. C., Kidd, J. R., Ruggeri, V., Palmatier, M. A., Goldman, D. A., Odunsi, A., Okonofua, F. E., Grigorenko, E. L., Schulz, L. O., Bonné, B., et al. (2002) · Human Genetics · doi:10.1007/s00439-002-0809-0 · Cited by 80
Karhunen, T., Tilgmann, C., Ulmanen, I., & Panul, P. (1995) · Neuroscience Letters · doi:10.1016/0304-3940(95)11337-v · Cited by 75
Wang, T., Franke, P. E., Neidt, H., Cichon, S., Knapp, M., Lichtermann, D., Maier, W., Propping, P., & Nöthen, M. M. (2000) · Molecular Psychiatry · doi:10.1038/sj.mp.4000803 · Cited by 74
Haplotypic association spanning the 22q11.21 genes COMT and ARVCF with schizophrenia
Sanders, A. R., Rusu, I., Duan, J., Molen, J. E. V., Hou, C., Schwab, S. G., Wildenauer, D. B., Martinez, M. M., & Gejman, P. V. (2004) · Molecular Psychiatry · doi:10.1038/sj.mp.4001586 · Cited by 74
Tenhunen, J., Salminen, M., Jalanko, A., UKKONEN, S., & Ulmanen, I. (1993) · DNA and Cell Biology · doi:10.1089/dna.1993.12.253 · Cited by 74
Lack of association of functional cathechol-O-methyltransferase gene polymorphism in schizophrenia
Strous, R. D., Bark, N. M., Woerner, M. G., & Lachman, H. M. (1997) · Biological Psychiatry · doi:10.1016/s0006-3223(96)00474-x · Cited by 74
Structure-based drug design of catechol-O-methyltransferase inhibitors for CNS disorders
Ma, Z., Liu, H., & Wu, B. (2013) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.12169 · Cited by 73
COMT haplotypes suggest P2 promoter region relevance for schizophrenia
Palmatier, M. A., PAKSTIS, A. J., Speed, W. C., Paschou, P., Goldman, D. A., Odunsi, A., Okonofua, F. E., Kajuna, S. L. B., Karoma, N. J., Kungulilo, S., et al. (2004) · Molecular Psychiatry · doi:10.1038/sj.mp.4001496 · Cited by 73
Lonsdorf, T. B., & Kalisch, R. (2011) · Translational Psychiatry · doi:10.1038/tp.2011.36 · Cited by 70
Hevir, N., Šinkovec, J., & Rižner, T. L. (2011) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2010.09.011 · Cited by 69
Disrupted Dopaminergic Neurotransmission in 22q11 Deletion Syndrome
Boot, E., Booij, J., Zinkstok, J., Abeling, N. G. G. M., de Haan, L., Baas, F., LINSZEN, D. H., & van Amelsvoort, T. (2007) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301508 · Cited by 68
A catechol- O -methyltransferase that is essential for auditory function in mice and humans
Du, X., Schwander, M., Moresco, E. M. Y., Viviani, P., Haller, C., Hildebrand, M. S., Pak, K. K., Tarantino, L. M., Roberts, A. J., Richardson, H. N., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0807219105 · Cited by 68
Role of COMT in ADHD: a Systematic Meta-Analysis
Sun, H., Yuan, F.-F., Shen, X., Xiong, G., & Wu, J. (2013) · Molecular Neurobiology · doi:10.1007/s12035-013-8516-5 · Cited by 70
Pharmacogenomics: Catechol-O-methyltransferase to thiopurine S-methyltransferase
Weinshilboum, R. M. (2006) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-006-9095-z · Cited by 66
The Catechol-O-Methyltransferase Gene
Tunbridge, E. M. (2010) · International review of neurobiology · doi:10.1016/b978-0-12-381326-8.00002-8 · Cited by 72
COMT (Val158Met) polymorphism is not associated to neuropathic pain in a Spanish population
Armero, P., Muriel, C., Santos, J., Sánchez-Montero, F. J., Rodróguez, R. E., & González‐Sarmiento, R. (2004) · European Journal of Pain · doi:10.1016/j.ejpain.2004.06.005 · Cited by 66
COMT genotype affects prefrontal white matter pathways in children and adolescents
Thomason, M. E., Dougherty, R. F., Colich, N. L., Perry, L. M., Rykhlevskaia, E. I., Louro, H. M. C., Hallmayer, J. F., Waugh, C. E., Bammer, R., Glover, G. H., et al. (2010) · NeuroImage · doi:10.1016/j.neuroimage.2010.01.033 · Cited by 67
PhRMA White Paper on ADME Pharmacogenomics
Williams, J. A., Andersson, T., Andersson, T. B., Blanchard, R. L., Behm, M. O., Cohen, N., Edeki, T. I., Franc, M. A., Hillgren, K. M., Johnson, K. J., et al. (2008) · The Journal of Clinical Pharmacology · doi:10.1177/0091270008319329 · Cited by 65
Walton, E., Liu, J., Haß, J., White, T. J. H., Scholz, M. R., Roessner, V., Gollub, R. L., Calhoun, V. D., & Ehrlich, S. (2014) · Epigenetics · doi:10.4161/epi.29223 · Cited by 65
Watanabe, M., Harada, S., Nakamura, T., Ohkoshi, N., Yoshizawa, K., Hayashi, A., & Shoji, S. (2003) · Neuropsychobiology · doi:10.1159/000074637 · Cited by 64
Sasaki, M., Kaneuchi, M., Sakuragi, N., & Dahiya, R. (2003) · PubMed · Cited by 64
Effects of Catechol-O-Methyltransferase on Normal Variation in the Cognitive Function of Children
Barnett, J. H., Heron, J., Goldman, D. A., Jones, P. B., & Xu, K. (2009) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2009.08081251 · Cited by 63
Saito, S., Iida, A., Sekine, A., Miura, Y., Sakamoto, T., Ogawa, C., Kawauchi, S., Higuchi, S., Nakamura, Y., & Nakamura, Y. (2001) · Journal of Human Genetics · doi:10.1007/s100380170035 · Cited by 63
Bastos, P., Gomes, T. M. B., & Ribeiro, L. V. P. T. (2017) · Reviews of physiology, biochemistry and pharmacology · doi:10.1007/112_2017_2 · Cited by 62
Zhu, G., Lipsky, R. H., Xu, K., Ali, S., Hyde, T. M., Kleinman, J. E., Akhtar, L. A., Mash, D. C., & Goldman, D. A. (2004) · Psychopharmacology · doi:10.1007/s00213-004-1938-z · Cited by 61
Raz, N., & Kennedy, K. M. (2009) · Oxford University Press eBooks · doi:10.1093/acprof:oso/9780195328875.003.0004 · Cited by 61
Cusin, C., Serretti, A., Lattuada, E., Lilli, R., Lorenzi, C., & Smeraldi, E. (2002) · American Journal of Medical Genetics · doi:10.1002/ajmg.10358 · Cited by 59
Héjjas, K., Enikö Kubinyi, B., Rónai, Z., Székely, A., Vas, J., Miklósi, Á., Sasvári‐Székely, M., & Kereszturi, É. (2009) · Genes Brain & Behavior · doi:10.1111/j.1601-183x.2008.00475.x · Cited by 58
Mukherjee, N., Kídd, K. K., PAKSTIS, A. J., Speed, W. C., Li, H., Tárnok, Z., Barta, C., Kajuna, S. L. B., & Kidd, J. R. (2008) · Molecular Psychiatry · doi:10.1038/mp.2008.64 · Cited by 59
Zhang, L., Jin, Y., Huang, M. T., & Penning, T. M. (2012) · Frontiers in Pharmacology · doi:10.3389/fphar.2012.00193 · Cited by 68
Goodman, J. E., Jensen, L. T., He, P., & Yager, J. D. (2002) · Pharmacogenetics · doi:10.1097/00008571-200210000-00003 · Cited by 55
Sazcı, A., Ergül, E., Küçükali, C. İ., Kılıç, G., Kaya, G., & Kara, İ. (2004) · Molecular Brain Research · doi:10.1016/j.molbrainres.2004.09.005 · Cited by 54
Toxicology and Safety of Comt Inhibitors
Haasio, K. (2010) · International review of neurobiology · doi:10.1016/b978-0-12-381326-8.00007-7 · Cited by 53
Kocabaş, N. A., Faghel, C., Barreto, M., Kasper, S. F., Linotte, S., Mendlewicz, J., Noro, M., Oswald, P., Souery, D., Zohar, J., et al. (2010) · International Clinical Psychopharmacology · doi:10.1097/yic.0b013e328338b884 · Cited by 55
Association of the catechol-O-methyltransferase val158met polymorphism and anxiety-related traits
Lee, L. O., & Prescott, C. A. (2013) · Psychiatric Genetics · doi:10.1097/ypg.0000000000000018 · Cited by 56
Metadata
- Authors
- TENHUNEN, J., SALMINEN, M., LUNDSTRÖM, K., KIVILUOTO, T., SAVOLAINEN, R., & ULMANEN, I.
- Affiliations
- Orion Corporation (Finland) (FI)
- Helsinki University Hospital (FI)
- Corresponding author
- TENHUNEN, Jukka
- ORCID
- SALMINEN, Marjo
- Venue
- European Journal of Biochemistry
- Publisher
- Wiley
- Published
- 1994-08
- Volume
- 223
- Issue
- 3
- Pages
- 1049-1059
- ISSN
- 0014-2956 (ISSN-L)
- 1432-1033
- OpenAlex
- W2135835694
- Cited by
- 331
- References
- 38
- Citations by year
- 2026: 6 · 2025: 2 · 2024: 1 · 2023: 7 · 2022: 7 · 2021: 7 · 2020: 6 · 2019: 13 · 2018: 2 · 2017: 6 · 2016: 15 · 2015: 4 · 2014: 14 · 2013: 16 · 2012: 12
- FWCI
- 7.31
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- European Journal of Biochemistry (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Pharmacogenetics and Drug Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Chromatin Dynamics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Associations and Epidemiology
- Keywords
- catechol-O-methyltransferase, COMT gene, gene structure, exon-intron organization, alternative transcription initiation, multiple promoters, proximal promoter, distal promoter, tissue-specific gene expression, membrane-bound COMT, 5' end mapping
- MeSH terms
- Animals, Base Sequence, Catechol O-Methyltransferase, Exons, Humans, Introns, Molecular Sequence Data, Promoter Regions, Genetic, RNA, Messenger, Sequence Homology, Nucleic Acid, Tissue Distribution, Transcription, Genetic, Genomic Library, Sequence Analysis, DNA, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
